AI-powered blood test allows for early breast cancer detection
SYDNEY : Australian scientists have developed the first artificial intelligence-powered lipid-based blood test, enabling earlier and less invasive breast cancer detection, Xinhua reported.
The test is already in use in specialist clinics across Sydney and Melbourne after transitioning from the research phase in March, according to a statement from the University of New South Wales (UNSW) published on Wednesday.
Unlike traditional imaging and biopsies, which can miss tumours and carry risks, the new AI-powered blood test detects subtle molecular signals in the blood.
This allows for cancer diagnosis months or even years before symptoms appear, said UNSW associate professor Fatemeh Vafaee.
AI drives the breakthrough by analysing millions of molecular markers to detect early cancer signs, according to the expert from Vafaee Lab, a biomedical AI laboratory at UNSW.
'By integrating explainable AI techniques, we ensure the models provide not only accurate outcomes but also clinically interpretable insights, which are crucial for building trust and supporting decision-making in real-world healthcare settings,' Vafaee said.
Contributing to global efforts to make AI-driven blood tests part of standard breast cancer screening, the lab offers a valuable new option, especially for women with dense breast tissue where traditional imaging may be less effective.
The team is now developing multi-analyte tests that combine various biomarkers for more precise cancer detection across multiple types, including lung, liver, and brain tumours.
They are also exploring tests using other biofluids like urine and saliva, while working to integrate diverse data for a complete view of patient health.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
13 minutes ago
- The Sun
Doctor-patient trust is key to unlocking AI's potential to improve healthcare in Australia, finds Philips' Future Health Index Report
• Two-thirds (66%) of Australians welcome technology for improved care, but more than half (53%) are concerned it will mean less face time with their doctor. • Three in four (74%) Australian healthcare professionals report losing clinical time due to incomplete or inaccessible patient data, with one fifth of these (19%) losing over 45 minutes per shift, amounting to 23 full days lost per year. • Australians are less optimistic about AI in healthcare (43%) compared to their healthcare providers (85%), highlighting a critical trust gap. SYDNEY, AUSTRALIA - Media OutReach Newswire - 6 August 2025 - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today released the Australian findings of its 10th edition of the Future Health Index 2025 report: Building trust in healthcare AI. For the first time, the report includes the perspectives of more than 1,000 Australian patients alongside their healthcare professionals, revealing a clear directive: Australians will embrace AI in healthcare, but only if it enhances, rather than replaces, the vital doctor-patient relationship. Whilst patients and providers see the potential for AI to address major challenges such as care delays and staff burnout, they believe its primary role should be to empower clinicians, allowing for more meaningful, human-centric care. 'This 10th edition of the Future Health Index gives us the clearest picture yet of what Australians want for their healthcare: technology must serve the human connection', said Shehaan Fernando, interim Managing Director of Philips Australia and New Zealand. 'For patients, building trust is as important as building technology. At Philips, we are committed to a human-centric vision for AI that empowers clinicians and strengthens the doctor-patient relationship that Australians value'. Patients welcome tech, but protect personal relationships The report uncovers a key tension in Australian attitudes towards technology. Whilst a majority (66%) of Australians welcome new technology if it improves the quality of their care, more than half (53%) express concern that it could lead to less direct interaction with their doctors. This desire for human connection is amplified by Australia's long-standing reliance on GP services as the foundation of the healthcare system. The findings suggest patients see AI's ideal role as a powerful support tool that handles administrative tasks, streamlines data access, and ultimately frees up GPs to engage in more in-depth, meaningful consultations. In Australia, three in four healthcare professionals (74%) report losing clinical time due to incomplete or inaccessible patient data, with one fifth of these (19%) losing more than 45 minutes per shift – adding up to 23 full days lost per healthcare professional each year[1]. AI's ability to manage and streamline patient data holds the key to reclaiming this time, allowing healthcare professionals to dedicate more focus to direct patient care. Doctors as trusted guides to AI When it comes to navigating the complexities of AI, Australians place their trust in their healthcare professionals. 79% of Australians would be most comfortable receiving information about AI in their care from their doctor, surpassing news outlets (48%) and social media (31%). This underscores the indispensable role of clinicians in guiding public acceptance and integration of AI. However, the report also notes that healthcare professionals themselves have questions, with 77% concerned or unclear about liability for AI errors. Australians are less optimistic about AI's benefits (43%) compared to their healthcare providers (84%), highlighting a critical trust gap. 'As clinicians, we see the incredible potential for AI to help us diagnose earlier and create more personalised treatment plans', said Dr Tim Bowles, Head of Department - HIVE (Health in a Virtual Environment), at East Metropolitan Health Service (EMHS) in Western Australia. 'AI can empower us to spend less time on administration and more time with our patients, ensuring technology elevates, rather than diminishes, the human element of care'. Philips' Commitment: Driving Human-Centred Innovation Philips' expertise in virtual hospital services and clinical command centres aligns with EMHS's efforts to improve patient-centred care and proactively detect the risk of patient deterioration. This collaboration, featuring the HIVE program and the deployment of a Clinical Command Centre solution leveraging machine learning and predictive analytics, has demonstrated significant patient outcomes. 'By integrating AI into our clinical workflows, we've been able to detect patient deterioration earlier, intervene faster, and ultimately deliver safer, more effective care. AI has become a vital tool in supporting our clinicians and improving outcomes when and where it matters most.' — Adam Lloyd, Area Director Community & Virtual Care East Metropolitan Health Service Data indicates the Clinical Command Centre has led to a 26% reduction in patient mortality[2], a 30% reduction in length of stay[3], and has helped 15% of patients be discharged home faster[4]. Furthermore, the program facilitated over 10,000 clinical interactions over a 12-month period, with 10% being for urgent or life-threatening reasons, and 64% of all interactions occurring after hours or on weekends. By integrating technology seamlessly into clinical workflows, Philips helps to augment the skills of healthcare professionals and improve patient care when it's needed most. 'Our long-term vision is to deliver responsible, human-centric AI that addresses the real-world challenges of patients and providers', said Shehaan Fernando, interim Managing Director of Philips Australia and New Zealand. 'By partnering with the medical community, we can ensure that innovation builds trust, improves outcomes, and supports a future of providing better care for more people'. For more information, or to download the full FHI 2025 Australia report, visit [1] FHI 2025 Australia report: Based on an eight-hour shift, working 250 days per year. This amounts to 187.50 hours lost per healthcare professional on average. [2] Lilly CM, et al. A Multi-center Study of ICU Telemedicine Reengineering of Adult Critical Care. CHEST. 2014; 145(3): 500-7. [3] Lilly CM, et al. Hospital Mortality, Length of Stay and Preventable Complications Among Critically Ill Patients Before and After Tele-ICU Reengineering of Critical Care Processes. JAMA. June 2011; 305(21) 2175-83.[5] Impact of an Intensive Care Unit Telemedicine Program on a Rural Health Care System. Zawada, et al. Postgrad Med J, 2009; 121(3):160-170. [4] Impact of an Intensive Care Unit Telemedicine Program on a Rural Health Care System. Zawada, et al. Postgrad Med J, 2009; 121(3):160-170.
Free Malaysia Today
2 hours ago
- Free Malaysia Today
Australia worried by Trump's threat to raise US pharma tariffs to 250%
US President Donald Trump said the US would first impose a 'small' tariff on foreign-made drugs before hiking it to 150% and eventually to 250%. (AP pic) SYDNEY : Australia is very concerned about US President Donald Trump's latest threat to raise tariffs on pharmaceutical imports by up to 250% over the longer term, its health minister said today. Trump said this week that the US would first impose a 'small' tariff on foreign-made drugs before hiking it to 150% within 18 months and eventually to 250% in an effort to boost domestic production. Mark Butler said the plan would be a blow to producers such as CSL, Australia's largest biotech company. 'And that is why we are working so hard to press the case for the continuation of free trade,' he told reporters. Medicines and pharmaceuticals are among Australia's top exports to the US, with around A$2.1 billion (US$1.4 billion) in shipments last year, according to the Australian Bureau of Statistics. There has been some bilateral tension over drug pricing in Australia. In a January submission to the US government, the Pharmaceutical Research and Manufacturers of America trade group said Australia's Pharmaceutical Benefits Scheme was 'egregious and discriminatory' and 'undervalued American innovation,' putting jobs and exports at risk. Butler said the national programme, which subsidises a wide range of prescription medicines for Australians, would not be changed to appease American companies and escape the threatened tariffs. 'To the extent that this is motivated by big pharma companies seeking to lobby the US administration to water down the protections of our PBS, it's simply not up for negotiation under our government,' he said.
Malay Mail
6 hours ago
- Malay Mail
Trump's 100pc tariff on foreign-made chips pressures Asian producers, Malaysia vows to ‘fight for its position'
TOKYO, Aug 7 — Donald Trump has announced a 100 per cent tariff on semiconductors from firms that do not invest in the United States — sparking volatility in Asian chipmaker shares today. The US president unveiled the levy at the White House yesterday ahead of the imposition of sweeping tariffs on goods from dozens of countries, with chips so far exempt. It comes with the United States and China locked in a high-stakes race to develop the high-end semiconductors used to power artificial intelligence systems. 'We'll be putting a tariff of approximately 100 per cent on chips and semiconductors, but if you're building in the United States... there's no charge,' Trump said. He did not give a timetable for the new levy, which he has repeatedly threatened in the past, to be enacted. Arisa Liu, senior semiconductor researcher at the Taiwan Institute of Economic Research, said it would impact the 'strategic direction of global semiconductor companies'. 'Since the United States is the world's largest player in AI and related high-performance computing, this will have a relatively greater impact on companies involved in advanced processes,' she said. 'The highest-end semiconductors will be excluded,' Alicia Garcia-Herrero, chief economist for Asia Pacific at Natixis, told AFP. But 'this kills producers of low-end chips', including those based in Malaysia or China, she warned. Today, shares in Taiwan's TSMC — world's largest contract maker of chips, which counts Nvidia and Apple among its clients — soared nearly five per cent after the government said the company would not be affected. Taiwan is a global powerhouse in semiconductor manufacturing, with more than half of the world's chips and nearly all of the high-end ones made there. 'Fight for Malaysia' Trump has previously accused Taiwan of having stolen the US chip industry, and earlier this year, TSMC unveiled a plan to invest an extra US$100 billion (RM422.7 billion) in the United States. Samsung Electronics, which is pumping billions into the United States, rose more than two per cent in Seoul, but a range of Japanese chip-making shares sank on the news. Apple is also investing an additional US$100 billion in the United States, Trump and the US tech giant's CEO Tim Cook announced yesterday, with Cook calling it 'the largest investment Apple has made in America'. Malaysian trade minister Datuk Seri Tengku Zafrul Abdul Aziz told parliament today that the country, a key chip manufacturing hub, was seeking an explanation from the US side. 'We will continue to fight for Malaysia to ensure that any policy changes or exemption criteria are communicated and negotiated in advance, and that Malaysia's position as a strategic partner is preserved,' he said. Chiang Min-yen, a non-resident fellow at the Research Institute for Democracy, Society, and Emerging Technology, said the tariff would hit legacy chipmakers who don't have the deep pockets to invest in the United States. 'Most of the legacy chip manufacturers in Taiwan, in the US, even in Japan... all face very serious, unfair market competition from Chinese competitors,' he said. If US policies undermine these companies' production efficiency, the Chinese competitors 'will be able to more easily enter the global market' and come to dominate the field in the future, Chiang told AFP. That 'would be very harmful for US industrialisation policies', he warned. 'In the end, we may have to rely more on the Chinese legacy chips, and it would hurt our cybersecurity or even national security.' — AFP
